Merck & Co., Inc. VRDN Holdings History
Number of Shares
93,414.00
Current Holdings Value*
$1.26 Mil
% of Portfolio
0.77%
Total Estimate Gain
$-436,243.38
% of Total Estimate Gain
-21.51%
Merck & Co., Inc.'s Viridian Therapeutics Inc Holding Summary
As of 2025-03-31, Merck & Co., Inc. held 93,414.00 shares of Viridian Therapeutics Inc(VRDN), totaling $1.26 Mil. This investment constitutes 0.77% of their stock portfolio, and Merck & Co., Inc. now holds 0.11% of the outstanding Viridian Therapeutics Inc(VRDN) stock.
The initial trade took place in 2024Q4. Based on historical transaction data and VRDN's current price of $17.04, Merck & Co., Inc.'s estimated gain on his VRDN holdings is $-436,243.38, reflecting a -21.51% gain to date.
Merck & Co., Inc. VRDN ($17.04) Holding Chart
Merck & Co., Inc. VRDN ($17.04) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers